Search

Author/Creator van Meerten, T.

1. MANTLE CELL LYMPHOMA OF MUCOSA‐ASSOCIATED LYMPHOID TISSUE: A RETROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF THE EUROPEAN MANTLE CELL LYMPHOMA NETWORK. (June 2017)

Authors:
Morello, L.; Rattotti, S.; Jerkeman, M.; van Meerten, T.; Krawczyk, K.; Moita, F.; Marino, D.; Ferrero, S.; Szymczyk, M.; Aurer, I.; El‐Galaly, T.C.; Di Rocco, A.; Carli, G.; Defrancesco, I.; Giordano, L.; Carlo‐Stella, C.; Dreyling, M.; Santoro, A.; Arcaini, L.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
202
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P1462: POPULATION-BASED REAL WORLD RESULTS OF CD19-DIRECTED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: A DUTCH CAR T-CELL TUMORBOARD EXPERIENCE. (23rd June 2022)

Authors:
Spanjaart, A. M.; Pennings, E.; Mutsaers, P.; van Dorp, S.; Jak, M.; van Doesem, J.; de Boer, J.; Vermaat, J.; Sijs-Szabo, A.; van der Poel, M.; Kuipers, I.; Chamuleau, M.; Nijhof, I.; Minnema, M.; Lugtenburg, P.; van Meerten, T.; Kersten, M. J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1344
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis. (December 2018)

Authors:
Montes de Jesus, F.M.; Kwee, T.C.; Nijland, M.; Kahle, X.U.; Huls, G.; Dierckx, R.A.J.O.; van Meerten, T.; Gheysens, O.; Dierickx, D.; Vergote, V.; Noordzij, W.; Glaudemans, A.W.J.M.
Journal:
Critical reviews in oncology/hematology
Issue:
Volume 132(2018)
Page Start:
27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. S211: CLINICAL AND PATIENT-REPORTED OUTCOMES IN A PHASE 3 STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VS STANDARD-OF-CARE IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (ZUMA-7). (23rd June 2022)

Authors:
Sureda, A.; Westin, J.; Locke, F. L.; Dickinson, M.; Ghobadi, A.; Elsawy, M.; van Meerten, T.; Miklos, D. B.; Ulrickson, M.; Perales, M.-A.; Farooq, U.; Wannesson, L.; Leslie, L.; Kersten, M. J.; Jacobson, C. A.; Pagel, J. M.; Wulf, G.; Johnston, P.; Rapoport, A. P.; Gordon, L. I.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
112
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT – A RETROSPECTIVE STUDY FROM THE LWP‐EBMT. (12th June 2019)

Authors:
Burney, C.N.; Robinson, S.; Boumendil, A.; Finel, H.; Khvedelidze, I.; Hunter, H.; Poire, X.; Lioure, B.; Peggs, K.; Foa, R.; Pillai, S.; van Meerten, T.; Bargay Lleonart, J.; Schmid, C.; Vergote, V.; Ganser, A.; Castagna, L.; Mufti, G.; Montoto, S.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
243
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗